Precision-Built Intermediates for
Advanced Pharmaceutical Synthesis
Building Blocks for a Healthier Tomorrow!
At PYG Lifesciences Private Limited is a manufacturer and Pharmaceutical CDMO for diverse range of high-quality API INTERMEDIATES that cater to various therapeutic segments.
Our Products
Search our active list of intermediates manufactured under strict GMP discipline.
2-Cyano-4-Bromo Methyl Biphenyl
| CAS NUMBER | 114772-54-2 |
| MOLECULAR FORMULA | C₁₄H₁₀BrN |
| MOLECULAR WEIGHT | 272.14 g/mol |
| COMMON NAME | Bromo-OTBN |
| APPLICATION / API | KSM for all Sartan Group of APIs |
2-Butyl-4-Chloro-5-Formyl-1H-Imidazole
| CAS NUMBER | 83857-96-9 |
| MOLECULAR FORMULA | C₈H₁₁ClN₂O |
| MOLECULAR WEIGHT | 186.64 g·mol⁻¹ |
| COMMON NAME | BCFI |
| APPLICATION / API | Losartan Potassium |
Glibenclamide
Sulfonamide
| CAS NUMBER | 16673-34-0 |
| MOLECULAR FORMULA | C₁₆H₁₇ClN₂O₄S |
| MOLECULAR WEIGHT | ≈ 368.83 g/mol |
| COMMON NAME | GLB |
| APPLICATION / API | Anti-Diabetic |
Glibenclamide Sodium Salt
| CAS NUMBER | 10238-21-8 (Parent) |
| MOLECULAR FORMULA | C₂₃H₂₇ClN₃NaO₅S |
| MOLECULAR WEIGHT | 516.0 g/mol |
| COMMON NAME | Glibenclamide Na |
| APPLICATION / API | Anti-Diabetic |
INTERMEDIATES FOR VARIOUS API / BULK DRUGS
Therapeutic Segments We Serve
Cardiovascular
- 2-Cyano-4-Bromo Methyl Biphenyl
- 2-Butyl-4-Chloro-5-Formyl-1H-Imidazole
Anti Diabetic
- Glibenclamide Sulfonamide
- Glibenclamide Sodium Salt
Products Under Development
Oncology
Respiratory
Neurological
ACTIVE R&D PIPELINES
Under Research And Development Stage
PYG Lifesciences is actively researching and developing new
API INTERMEDIATES for various therapeutic segments, including:
Anti Diabetic API INTERMEDIATES
These API Intermediates are designed to manage blood sugar levels in diabetic patients.
Anti-histamine API INTERMEDIATES
Anti-histamine API Intermediates are used to treat allergies and other conditions associated with histamine release.
PRODUCTS
High Potency & API INTERMEDIATES
We specialize in the advanced synthesis of complex building blocks and High Potency API Intermediates (HPAPIs) under strict containment protocols. Leveraging our state-of-the-art glass-lined reactor infrastructure and specialized engineering controls, we ensure cross-contamination prevention and high-yield chemical processing. Our facilities are equipped to scale up custom synthesis and CDMO requirements from R&D to commercial production, serving critical therapeutic areas including Oncology, Cardiovascular, and Pain Management with stringent quality assurance.
CDMO BASED PARTNERSHIP
Contract Manufacturing
At PYG Lifesciences, we understand the critical role of reliable API manufacturing in bringing innovative healthcare solutions to patients worldwide. We go beyond simply producing chemicals — we offer comprehensive Contract Manufacturing Services tailored to meet the specific needs of Multinational Corporations (MNCs) in the pharmaceutical industry. We strive to become your trusted extension, providing the high-quality APIs, exceptional service, and ongoing support you need to succeed.